×
About 298 results

ALLMedicine™ Acral Lentiginous Melanoma Center

Research & Reviews  109 results

Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subt...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655663
JAMA Dermatology; Cheraghlou S, Ugwu N et. al.

Dec 9th, 2021 - Acral lentiginous melanoma (ALM) is a rare subtype of malignant melanoma typically occurring on the palmar and plantar surfaces. Although it has distinctive genetic, prognostic, and behavioral characteristics relative to cutaneous melanomas overal...

Racial and socioeconomic differences in acral lentiginous melanoma outcomes: A Surveill...
https://doi.org/10.1016/j.jaad.2021.11.023
Journal of the American Academy of Dermatology; Raval NS, Hodges WT et. al.

Nov 24th, 2021 - Racial and socioeconomic differences in acral lentiginous melanoma outcomes: A Surveillance, Epidemiology, and End Results analysis.|2021|Raval NS,Hodges WT,Ugwu-Dike PO,Godoy F,Ansstas G,|

Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581784
Cancer Control : Journal of the Moffitt Cancer Center; Kolla AM, Vitiello GA et. al.

Nov 10th, 2021 - Acral lentiginous melanoma is associated with worse survival than other subtypes of melanoma. Understanding prognostic factors for survival and recurrence can help better inform follow-up care. To analyze the clinicopathologic features, melanoma-s...

Acral lentiginous melanoma with HER2/ErbB2 amplification.
https://doi.org/10.1684/ejd.2021.4115
European Journal of Dermatology : EJD; Donzel M, Harou O et. al.

Oct 14th, 2021 - Acral lentiginous melanoma with HER2/ErbB2 amplification.|2021|Donzel M,Harou O,Skowron F,Dalle S,Descotes F,|

see more →

Clinicaltrials.gov  2 results

Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma
https://clinicaltrials.gov/ct2/show/NCT02875132

Jul 28th, 2021 - To determine the Overall Response Rate (ORR), as defined as rate of complete response (CR) and partial response (PR) as per RECIST 1.1 in biological treatment-naïve patients with acral lentiginous melanoma treated with pembrolizumab

A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
https://clinicaltrials.gov/ct2/show/NCT02978443

Jan 10th, 2020 - Immunotherapy with HD-IL-2 has produced durable benefit in 10% of patients with metastatic cutaneous melanoma. The antitumor activity of IL-2 has been limited at least in part by immunosuppressive and immune-regulatory forces within the tumor micr...

see more →

News  8 results

Palbociclib Demonstrates Activity in Acral Lentiginous Melanoma Subtype
https://www.onclive.com/view/palbociclib-demonstrates-activity-in-acral-lentiginous-melanoma-subtype

Dec 5th, 2020 - The CDK4/6 inhibitor palbociclib (Ibrance) exhibited preliminary activity in patients with acral lentiginous melanoma (ALM) associated with CDK-pathway aberrations, according to results of a small phase II trial that were reported at the 2019 ASCO...

Dermoscopic Patterns of Acral Melanocytic Lesions in Skin of Color
https://www.mdedge.com/dermatology/article/200163/melanoma/dermoscopic-patterns-acral-melanocytic-lesions-skin-color/page/0/1?channel=244

May 3rd, 2019 - Dermoscopic Patterns of Acral Volar Skin Dermoscopy is a useful noninvasive tool for distinguishing between benign and malignant acral melanocytic lesions, and its efficacy in improving diagnostic accuracy and decreasing unnecessary biopsies is we.

Pigmentation on foot
https://www.mdedge.com/familymedicine/article/196329/dermatology/pigmentation-foot?channel=114
MDedge Family Medicine;

Mar 14th, 2019 - The FP suspected that this was an acral lentiginous melanoma (ALM). The FP considered the various ways to biopsy this lesion.

Pigmentation on foot
https://www.mdedge.com/familymedicine/article/196329/dermatology/pigmentation-foot
MDedge Family Medicine;

Mar 14th, 2019 - The FP suspected that this was an acral lentiginous melanoma (ALM). The FP considered the various ways to biopsy this lesion.

National Study: Acral Lentiginous Melanoma Incidence Remains Steady
https://www.mdedge.com/dermatology/article/10022/melanoma/national-study-acral-lentiginous-melanoma-incidence-remains
Bruce Jancin

SAN FRANCISCO — Acral lentiginous is the rarest of the major histologic subtypes of melanoma, but is the most common subtype in blacks, according to a national study. The study showed that the age-adjusted incidence of acral lentiginous melanoma (.

see more →